CervoMed (CRVO) Invested Capital (2022 - 2025)
Historic Invested Capital for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to $26.0 million.
- CervoMed's Invested Capital fell 4300.42% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.0 million, marking a year-over-year decrease of 4300.42%. This contributed to the annual value of $39.2 million for FY2024, which is 43142.92% up from last year.
- As of Q3 2025, CervoMed's Invested Capital stood at $26.0 million, which was down 4300.42% from $33.4 million recorded in Q2 2025.
- CervoMed's Invested Capital's 5-year high stood at $50.0 million during Q2 2024, with a 5-year trough of -$35.1 million in Q2 2023.
- For the 4-year period, CervoMed's Invested Capital averaged around $15.4 million, with its median value being $26.0 million (2025).
- As far as peak fluctuations go, CervoMed's Invested Capital crashed by 23165.62% in 2023, and later surged by 54902.61% in 2025.
- CervoMed's Invested Capital (Quarter) stood at -$33.3 million in 2022, then soared by 122.16% to $7.4 million in 2023, then surged by 431.43% to $39.2 million in 2024, then plummeted by 33.65% to $26.0 million in 2025.
- Its Invested Capital stands at $26.0 million for Q3 2025, versus $33.4 million for Q2 2025 and $34.6 million for Q1 2025.